This prospective longitudinal study will follow participants with Multifocal Motor Neuropathy over time and collect data on their clinical outcomes, quality of life, and use of health care resources. Participants will follow their regular visit schedule with their treating physician, except for an optional second visit occurring 7 to 14 days after the start of the study to collect biomarker data. No IMP will be administered.
Study Type
OBSERVATIONAL
Enrollment
413
To characterize MMN patient profiles for participants
Time frame: up to 37 months
To assess the MMN disease management and disease course
Time frame: up to 37 months
To assess outcome measures specific to MMN disease and their evolution over time
Time frame: up to 37 months
To estimate the burden of MMN on participants' quality of life
Time frame: up to 37 months
To estimate the economic burden for participants with MMN
Time frame: up to 37 months
To collect data on relevant disease biomarkers
Time frame: up to 37 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Neuromuscular Clinical and Research Center
Phoenix, Arizona, United States
HonorHealth Neurology - Bob Bove Neuroscience Institute
Scottsdale, Arizona, United States
UCI Health - ALS and Neuromuscular Center
Orange, California, United States
Stanford Medicine Health Care - Stanford Neuroscience Health Center
Palo Alto, California, United States
The Neurology Group
Pomona, California, United States
Eisenhower Health - Rancho Mirage Medical Center
Rancho Mirage, California, United States
UC Davis Health - Lawrence J. Ellison Ambulatory Care Center
Sacramento, California, United States
UCSF Health - UCSF Medical Center
San Francisco, California, United States
University of Colorado - Anschutz Medical Campus
Aurora, Colorado, United States
YaleNewHavenHealth - Yale New Haven Hospital
New Haven, Connecticut, United States
...and 103 more locations